NIDCR FY 2024 Funding Policy

Underlying NIDCR’s Financial Management Plan is the institute’s goal to provide stable levels of support for high quality scientific research and research training.

NIDCR is operating under the Further Consolidated Appropriations Act, 2024 (Public Law 118-47) signed by President Biden on March 23, 2024.

FY 2024 Competing Policy

NIDCR will continue to provide individual consideration to all competing applications. For all competing modular R01 and R01 equivalent applications selected for funding, NIDCR intends to reduce applications by at least 9% below the peer review recommended level of support. For all competing non-modular R01 and R01 equivalent applications selected for funding, NIDCR intends to reduce applications by at least 15% below the peer review recommended level of support. For well-funded NIDCR investigators, additional reductions may be considered.

All research project grant (RPG) applications submitted on or after January 25, 2023, competing renewal (Type 2) applications are expected to be limited to no more than a 20% budget increase over the last non-competing award.

For all competing research training and career development award applications selected for funding, NIDCR intends to continue providing funding at the NIDCR specific allowable costs and/or the peer review recommended level of support.

FY 2024 Non-Competing Policy

In accordance with NIH fiscal policy (as explained in the Notice of Fiscal Policies in Effect for FY 2024), the following activity codes: R01, R33, R35, R37, U01, U19, UH3, U24, and P50 will be reduced by 2% from the amount recommended on the previous Notice of Grant Award. All other non-competing continuation awards made in FY 2024 will be issued at the commitment level indicated on the notice of award.

To optimize resources, projects with large unobligated balances (25% or more of total approved budget) without an approved expenditure plan may receive additional adjustments based on the justification provided.

When making funding decisions, NIDCR may consider other relevant factors such as, but not limited to, scores assigned during peer review, new scientific opportunities, current research priorities, portfolio balance, and alignment with the NIDCR Strategic Plan 2021-2026 and availability of funds.

Consistent with the NIH Next Generation Researchers Initiative, NIDCR is committed to support a robust and diverse workforce through additional funding consideration for supporting Early Stage Investigators (ESIs) and At-risk Investigators. All competing ESI non-modular applications will be reduced by 10% and modular applications will not be affected.